Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings

C. Jonsson-Oldenbuettel, J. Ghosn, M. van der Valk, E. Florence, F. Vera, M. Ait-Khaled, G. Bontempo, C. Latham, C. A. Gutner, S. Iyer, R. DeMoor, M. Gill, M. Czarnogorski, J. van Wyk

Research output: Contribution to journalConference abstract in journal

Original languageEnglish
JournalJournal of the International AIDS Society
Pages (from-to)241-242
Number of pages2
Publication statusPublished - 2022

Cite this